JPWO2020178638A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020178638A5 JPWO2020178638A5 JP2021552586A JP2021552586A JPWO2020178638A5 JP WO2020178638 A5 JPWO2020178638 A5 JP WO2020178638A5 JP 2021552586 A JP2021552586 A JP 2021552586A JP 2021552586 A JP2021552586 A JP 2021552586A JP WO2020178638 A5 JPWO2020178638 A5 JP WO2020178638A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- patient
- stage
- antibody
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025003299A JP2025063135A (ja) | 2019-03-05 | 2025-01-09 | Ａｌアミロイドーシスを処置する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962814252P | 2019-03-05 | 2019-03-05 | |
| US62/814,252 | 2019-03-05 | ||
| US201962942722P | 2019-12-02 | 2019-12-02 | |
| US62/942,722 | 2019-12-02 | ||
| PCT/IB2020/000186 WO2020178638A1 (en) | 2019-03-05 | 2020-03-05 | Methods of treating al amyloidosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025003299A Division JP2025063135A (ja) | 2019-03-05 | 2025-01-09 | Ａｌアミロイドーシスを処置する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022522889A JP2022522889A (ja) | 2022-04-20 |
| JPWO2020178638A5 true JPWO2020178638A5 (enExample) | 2023-03-13 |
| JP7619953B2 JP7619953B2 (ja) | 2025-01-22 |
Family
ID=70476256
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552586A Active JP7619953B2 (ja) | 2019-03-05 | 2020-03-05 | Ａｌアミロイドーシスを処置する方法 |
| JP2025003299A Pending JP2025063135A (ja) | 2019-03-05 | 2025-01-09 | Ａｌアミロイドーシスを処置する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025003299A Pending JP2025063135A (ja) | 2019-03-05 | 2025-01-09 | Ａｌアミロイドーシスを処置する方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US11692024B2 (enExample) |
| EP (2) | EP3934689B1 (enExample) |
| JP (2) | JP7619953B2 (enExample) |
| KR (1) | KR20220019656A (enExample) |
| CN (1) | CN113811332A (enExample) |
| AU (1) | AU2020231081A1 (enExample) |
| BR (1) | BR112021017550A2 (enExample) |
| CA (1) | CA3132780A1 (enExample) |
| CL (1) | CL2021002318A1 (enExample) |
| FR (1) | FR3111560B1 (enExample) |
| IL (1) | IL286040A (enExample) |
| JO (1) | JOP20210245A1 (enExample) |
| MA (1) | MA55209A (enExample) |
| MX (1) | MX2021010665A (enExample) |
| PH (1) | PH12021552135A1 (enExample) |
| SG (1) | SG11202109645QA (enExample) |
| WO (1) | WO2020178638A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7619953B2 (ja) * | 2019-03-05 | 2025-01-22 | プロシーナ バイオサイエンシーズ リミテッド | Ａｌアミロイドーシスを処置する方法 |
| JP2023541191A (ja) * | 2020-09-14 | 2023-09-28 | ケーラム バイオサイエンシーズ， インコーポレイテッド | アミロイドーシスを治療する方法 |
| TW202332465A (zh) * | 2021-01-29 | 2023-08-16 | 愛爾蘭商普羅希那生物科學有限公司 | 治療al類澱粉變性症之方法 |
| CN118749002A (zh) * | 2022-01-11 | 2024-10-08 | 普罗塞纳生物科学有限公司 | 治疗al淀粉样变性的方法 |
| AR132344A1 (es) * | 2023-04-10 | 2025-06-18 | Medimmune Llc | Optimización de los dominios de unión al antígeno cd3 |
| WO2025170969A1 (en) * | 2024-02-06 | 2025-08-14 | Prothena Biosciences Limited | Methods of treating al amyloidosis |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030147882A1 (en) | 1998-05-21 | 2003-08-07 | Alan Solomon | Methods for amyloid removal using anti-amyloid antibodies |
| PT1355919E (pt) | 2000-12-12 | 2011-03-02 | Medimmune Llc | Moléculas com semivida longa, composições que as contêm e suas utilizações |
| AU2005235811B2 (en) | 2004-02-06 | 2011-11-03 | Morphosys Ag | Anti-CD38 human antibodies and uses therefor |
| EP3312196B1 (en) | 2005-03-23 | 2019-07-17 | Genmab A/S | Antibodies against cd38 for treatment of multiple myeloma |
| ES2544679T3 (es) | 2007-12-28 | 2015-09-02 | Prothena Biosciences Limited | Tratamiento y profilaxis de la amiloidosis |
| EP3613774A1 (en) | 2010-06-09 | 2020-02-26 | Genmab A/S | Antibodies against human cd38 |
| PE20191242A1 (es) | 2011-10-25 | 2019-09-16 | Prothena Biosciences Ltd | Formulaciones de anticuerpo y metodos |
| CN104023748B (zh) | 2011-10-28 | 2018-03-02 | 诚信生物公司 | 含有氨基酸的蛋白质制剂 |
| US10213506B2 (en) | 2014-08-26 | 2019-02-26 | University Of Tennessee Research Foundation | Targeting immunotherapy for amyloidosis |
| BR112017024877A2 (pt) | 2015-05-20 | 2019-09-17 | Janssen Biotech, Inc. | anticorpo anti-cd38 e seu uso no tratamento de amiloidose de cadeia leve e outras malignidades hematológicas positivas para cd38 |
| MD3827845T2 (ro) | 2015-11-03 | 2022-09-30 | Janssen Biotech Inc | Formulări subcutanate de anticorpi anti-CD38 și utilizări ale acestora |
| HRP20220979T8 (hr) * | 2016-06-30 | 2023-02-03 | Prothena Biosciences Limited | Sastavi za liječenje amiloidoze |
| US11382974B2 (en) | 2017-08-01 | 2022-07-12 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for treatment of amyloid deposition diseases |
| US12018069B2 (en) | 2018-06-28 | 2024-06-25 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for imaging amyloid deposits |
| CN113924099A (zh) | 2019-02-12 | 2022-01-11 | 普罗塞纳生物科学有限公司 | 针对免疫球蛋白轻链的单克隆抗体与抗体产生细胞和其他免疫细胞上的cd38细胞膜分子的组合治疗al淀粉样变性 |
| JP7619953B2 (ja) * | 2019-03-05 | 2025-01-22 | プロシーナ バイオサイエンシーズ リミテッド | Ａｌアミロイドーシスを処置する方法 |
| TW202332465A (zh) | 2021-01-29 | 2023-08-16 | 愛爾蘭商普羅希那生物科學有限公司 | 治療al類澱粉變性症之方法 |
-
2020
- 2020-03-05 JP JP2021552586A patent/JP7619953B2/ja active Active
- 2020-03-05 AU AU2020231081A patent/AU2020231081A1/en active Pending
- 2020-03-05 WO PCT/IB2020/000186 patent/WO2020178638A1/en not_active Ceased
- 2020-03-05 US US16/810,319 patent/US11692024B2/en active Active
- 2020-03-05 CA CA3132780A patent/CA3132780A1/en active Pending
- 2020-03-05 KR KR1020217031814A patent/KR20220019656A/ko active Pending
- 2020-03-05 MA MA055209A patent/MA55209A/fr unknown
- 2020-03-05 SG SG11202109645Q patent/SG11202109645QA/en unknown
- 2020-03-05 EP EP20722638.2A patent/EP3934689B1/en active Active
- 2020-03-05 EP EP25163966.2A patent/EP4582446A3/en active Pending
- 2020-03-05 JO JOP/2021/0245A patent/JOP20210245A1/ar unknown
- 2020-03-05 CN CN202080033593.5A patent/CN113811332A/zh active Pending
- 2020-03-05 BR BR112021017550A patent/BR112021017550A2/pt unknown
- 2020-03-05 PH PH1/2021/552135A patent/PH12021552135A1/en unknown
- 2020-03-05 MX MX2021010665A patent/MX2021010665A/es unknown
-
2021
- 2021-06-16 FR FR2106376A patent/FR3111560B1/fr active Active
- 2021-09-01 IL IL286040A patent/IL286040A/en unknown
- 2021-09-03 CL CL2021002318A patent/CL2021002318A1/es unknown
-
2023
- 2023-05-08 US US18/313,792 patent/US12240894B2/en active Active
-
2025
- 2025-01-09 JP JP2025003299A patent/JP2025063135A/ja active Pending
- 2025-03-03 US US19/068,630 patent/US20250188159A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7575526B2 (ja) | Ｉｌ－４ｒ阻害剤の投与によるアレルギー処置方法およびアレルゲン特異的免疫療法の向上方法 | |
| KR102196009B1 (ko) | 항체 제형 및 방법 | |
| BRPI0615745A2 (pt) | formulação de anticorpo anti-cd3 | |
| RU2016103079A (ru) | Составы антител и способы | |
| JPH08506091A (ja) | 造血幹細胞の末梢化 | |
| CA3147068A1 (en) | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r antagonist | |
| JPWO2020178638A5 (enExample) | ||
| JP2006501283A (ja) | ＬＦＡ−１αサブユニット抗体と利用方法 | |
| CN119486744A (zh) | 艾萨妥昔单抗联合其他药物用于治疗多发性骨髓瘤的用途 | |
| JP3973360B2 (ja) | 関節リウマチまたは皮膚疾患の処置に使用するためのｃｄ２５結合分子 | |
| US20260070995A1 (en) | Methods for treating bullous pemphigoid by administering an il-4r antagonist | |
| JPWO2022162625A5 (enExample) | ||
| Stevenson | The prospects for treating cancer with antibody | |
| WO1994023747A1 (de) | Arzneimittel, das antikörper enthält, zur behandlung von t-zell spezifischen immunreaktionen und t-zell-leukämien | |
| WO2026022712A1 (en) | Cereblon ligase modulator and bcma nk cell engager combination therapy | |
| WO2025124481A1 (zh) | Tfpi抗体用于治疗血友病 | |
| JPWO2020167376A5 (enExample) | ||
| JPWO2023036745A5 (enExample) | ||
| EP4622669A1 (en) | Methods for improving bone growth by administering an il-4r antagonist | |
| RU2021135507A (ru) | Антитела к cd40 для применения в лечении t1dm и инсулита | |
| JPWO2021118999A5 (enExample) | ||
| HK1216898B (en) | Methods for enhancing allergen-specific immunotherapy by administering an il-4r inhibitor | |
| EP0765171A1 (en) | Treatment of autoimmune and inflammatory disorders |